Knight Therapeutics Incis A Canadian Specialty Pharmaceutical Company Based In Montrealquebecit Operates Across Canada And Ten Countries In Latin Americafocusing On Acquiringin Licensingmarketingand Commercializing Innovative Prescription Pharmaceuticalsthe Company Employs Over 700 People And Is Publicly Traded On The Toronto Stock Exchange Under The Symbol Gud The Company Engages In Various Servicesincluding Acquiring Pharmaceutical Products From International Manufacturers And Obtaining Regulatory Approvals For Marketing In Its Target Regionsknight Therapeutics Has A Diverse Portfolio Of Products Across Therapeutic Areas Such As Pain Managementophthalmologywomen S Healthand Oncologynotable Products Include Movantik For Opioid Induced Constipationprobuphine For Opioid Dependenceand Impavido For Leishmaniasisknight Therapeutics Is Committed To Building A Leading Specialty Pharmaceutical Company By Delivering Innovative Products While Adhering To Strong Corporate Governance Principlesits Mission Reflects A Dedication To Serving Healthcare Providers And Patients In Its Markets
